ArticleBMC infectious diseases2025
Early identification and diagnosis of fournier gangrene: a machine learning approach integrating serological characterization.
Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundFournier Gangrene (FG) and Generalized Perianal Abscess (GPA) have similar clinical features. But FG has a high mortality and disability rate and needs to be identified and treated as early as possible. This study utilized machine learning methods to integrate clinical and metabolic features to promote early diagnosis of FG.
methodsSerological characteristics were screened for patients with FG (n = 20) and GPA (n = 16). The metabolomic changes of FG were described based on untargeted metabolomics. We used machine learning tools to combine demographic data, clinical serology, and metabolomics data to establish disease-specific boundary points.
resultsThere were significant differences in the serum metabolic profiles between the FG and GPA groups. 118 different metabolites were detected, mainly fatty acids. Based on machine learning integration of metabolic and clinical features, a differential diagnosis combination of Myo-inositol (MI), Procalcitonin (PCT) and Bistris was established for early identification and diagnosis of FG. The diagnostic performance was evaluated using GBDT, SVM, and LR algorithms, demonstrating robust discriminative ability (AUC: 0.80, 0.82, and 0.95; sensitivity: 0.90, 0.92, and 1.00). In addition, we identified 14 differential metabolic pathways. The activation of Necroptosis may lead to the occurrence of explosive perianal and perineal infections.
conclusionOur findings provide a biomarker combination for early diagnosis of FG in clinical applications. On the other hand, it provides important insights into the pathological mechanism differences between FG and GPA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.